Symptomatic COVID-19 Infection Laboratory-Confirmed
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09053 | Ibrutinib | 1 | Completed | 1 |
| DB11105 | Benzalkonium | 1 / 2 | Suspended | 1 |
| DB05258 | Interferon alfa | 1 / 2 | Suspended | 1 |
| DB00105 | Interferon alfa-2b | 1 / 2 | Suspended | 1 |
| DB01097 | Leflunomide | 1 / 2 | Active Not Recruiting | 1 |
| DB16425 | Rintatolimod | 1 / 2 | Suspended | 1 |
| DB11817 | Baricitinib | 2 | Terminated | 1 |
| DB01254 | Dasatinib | 2 | Withdrawn | 1 |
| DB01611 | Hydroxychloroquine | 2 | Terminated | 1 |
| DB09053 | Ibrutinib | 2 | Withdrawn | 1 |
| DB01601 | Lopinavir | 2 | Withdrawn | 1 |
| DB00503 | Ritonavir | 2 | Withdrawn | 1 |
| DB06273 | Tocilizumab | 2 | Terminated | 1 |